Assessment of Adherence to Clinical Guidelines in Patients with Chronic Hepatitis B.
Viruses. 2022 Oct 11;14(10):2229. doi: 10.3390/v14102229.
Viruses. 2022.
PMID: 36298784
Free PMC article.
Review.
Search Page
Filters
Search Results
102 results
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Pros and Cons of Peginterferon Versus Nucleos(t)ide Analogues for Treatment of Chronic Hepatitis B.
Curr Hepat Rep. 2010 May;9(2):91-98. doi: 10.1007/s11901-010-0041-7. Epub 2010 Apr 15.
Curr Hepat Rep. 2010.
PMID: 20461129
Free PMC article.
Prediction of sustained response to peginterferon alfa-2b for hepatitis B e antigen-positive chronic hepatitis B using on-treatment hepatitis B surface antigen decline.
Hepatology. 2010 Oct;52(4):1251-7. doi: 10.1002/hep.23844.
Hepatology. 2010.
PMID: 20830787
Clinical Trial.
Kinetics of hepatitis B surface antigen differ between treatment with peginterferon and entecavir.
J Hepatol. 2011 Mar;54(3):449-54. doi: 10.1016/j.jhep.2010.07.046. Epub 2010 Nov 5.
J Hepatol. 2011.
PMID: 21112655
Clinical Trial.
Chronic hepatitis B: peginterferon or nucleos(t)ide analogues?
Liver Int. 2011 Jan;31 Suppl 1:78-84. doi: 10.1111/j.1478-3231.2010.02384.x.
Liver Int. 2011.
PMID: 21205142
Review.
A comparison of two assays for quantification of Hepatitis B surface Antigen in patients with chronic hepatitis B.
J Clin Virol. 2011 Jul;51(3):175-8. doi: 10.1016/j.jcv.2011.04.005. Epub 2011 May 17.
J Clin Virol. 2011.
PMID: 21592855
Free article.
Polymorphisms near IL28B and serologic response to peginterferon in HBeAg-positive patients with chronic hepatitis B.
Gastroenterology. 2012 Mar;142(3):513-520.e1. doi: 10.1053/j.gastro.2011.11.025. Epub 2011 Nov 19.
Gastroenterology. 2012.
PMID: 22108195
Quantification of serum hepatitis B surface antigen: is it useful for the management of chronic hepatitis B?
Gut. 2012 May;61(5):641-5. doi: 10.1136/gutjnl-2011-301096. Epub 2011 Dec 16.
Gut. 2012.
PMID: 22180061
Review.
No abstract available.
Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-α2b: relation to response and HBV genotype.
Antivir Ther. 2012;17(1):9-17. doi: 10.3851/IMP1887.
Antivir Ther. 2012.
PMID: 22267464
Clinical Trial.
Presence of precore and core promoter mutants limits the probability of response to peginterferon in hepatitis B e antigen-positive chronic hepatitis B.
Hepatology. 2012 Jul;56(1):67-75. doi: 10.1002/hep.25636. Epub 2012 Apr 25.
Hepatology. 2012.
PMID: 22307831
Clinical Trial.
Cite